"Ethanolamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives.
| Descriptor ID |
D004983
|
| MeSH Number(s) |
D02.033.100.291 D02.033.375.291 D02.092.063.291
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ethanolamines".
Below are MeSH descriptors whose meaning is more specific than "Ethanolamines".
This graph shows the total number of publications written about "Ethanolamines" by people in this website by year, and whether "Ethanolamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 3 | 0 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 7 | 1 | 8 |
| 2018 | 4 | 0 | 4 |
| 2019 | 1 | 1 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Ethanolamines" by people in Profiles.
-
N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARa. J Neuroimmunol. 2021 09 15; 358:577654.
-
Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results. Eur Rev Med Pharmacol Sci. 2021 06; 25(11):4156-4162.
-
Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation. Prostaglandins Other Lipid Mediat. 2021 06; 154:106540.
-
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies. J Chem Inf Model. 2020 12 28; 60(12):5754-5770.
-
Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19. Med Hypotheses. 2020 Oct; 143:109856.
-
The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice. FASEB J. 2019 10; 33(10):11364-11380.
-
Dynamic changes of key metabolites during liver fibrosis in rats. World J Gastroenterol. 2019 Feb 28; 25(8):941-954.
-
Effects of a new compound containing Palmitoylethanolamide and Baicalein in myocardial ischaemia/reperfusion injury in vivo. Phytomedicine. 2019 Feb 15; 54:27-42.
-
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. J Psychiatr Res. 2018 08; 103:104-111.
-
Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole Blood. Clin Chem. 2018 05; 64(5):810-819.